1. Home
  2. JMM vs ARMP Comparison

JMM vs ARMP Comparison

Compare JMM & ARMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JMM
  • ARMP
  • Stock Information
  • Founded
  • JMM 1988
  • ARMP N/A
  • Country
  • JMM United States
  • ARMP United States
  • Employees
  • JMM N/A
  • ARMP N/A
  • Industry
  • JMM Trusts Except Educational Religious and Charitable
  • ARMP Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • JMM Finance
  • ARMP Health Care
  • Exchange
  • JMM Nasdaq
  • ARMP Nasdaq
  • Market Cap
  • JMM 58.5M
  • ARMP 52.1M
  • IPO Year
  • JMM N/A
  • ARMP N/A
  • Fundamental
  • Price
  • JMM $6.18
  • ARMP $1.95
  • Analyst Decision
  • JMM
  • ARMP Strong Buy
  • Analyst Count
  • JMM 0
  • ARMP 1
  • Target Price
  • JMM N/A
  • ARMP $9.00
  • AVG Volume (30 Days)
  • JMM 16.1K
  • ARMP 624.1K
  • Earning Date
  • JMM 01-01-0001
  • ARMP 05-14-2025
  • Dividend Yield
  • JMM 5.44%
  • ARMP N/A
  • EPS Growth
  • JMM N/A
  • ARMP N/A
  • EPS
  • JMM N/A
  • ARMP N/A
  • Revenue
  • JMM N/A
  • ARMP $4,699,000.00
  • Revenue This Year
  • JMM N/A
  • ARMP $8.43
  • Revenue Next Year
  • JMM N/A
  • ARMP N/A
  • P/E Ratio
  • JMM N/A
  • ARMP N/A
  • Revenue Growth
  • JMM N/A
  • ARMP 14.24
  • 52 Week Low
  • JMM $5.29
  • ARMP $0.90
  • 52 Week High
  • JMM $6.10
  • ARMP $3.42
  • Technical
  • Relative Strength Index (RSI)
  • JMM 55.51
  • ARMP 56.79
  • Support Level
  • JMM $6.05
  • ARMP $1.74
  • Resistance Level
  • JMM $6.21
  • ARMP $2.20
  • Average True Range (ATR)
  • JMM 0.12
  • ARMP 0.32
  • MACD
  • JMM 0.00
  • ARMP 0.04
  • Stochastic Oscillator
  • JMM 63.33
  • ARMP 50.32

About JMM Nuveen Multi-Market Income Fund (MA)

Nuveen Multi-Market Income Fund is a United States-based closed-end management investment company. The investment objective of the company is to provide high monthly income consistent with prudent risk to capital. The fund predominantly invests in debt securities including, but not limited to residential and commercial mortgage-backed securities, asset-backed securities, corporate debt obligations, convertible debt securities, U.S. government securities, and other such fixed income instruments. It may also invest in preferred stocks.

About ARMP Armata Pharmaceuticals Inc.

Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.

Share on Social Networks: